|
 MedWatch - The FDA Safety Information and Adverse Event Reporting Program
Today, the U.S. Food and Drug Administration (FDA) updated the SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests web page to share the latest information.
-
Background on the SARS-CoV-2 omicron variant
-
Information on the impact of the SARS-CoV-2 omicron variant on antigen diagnostic tests
-
The FDA’s recommendations for clinical laboratory staff and health care providers
-
Information on the impact of the SARS-CoV-2 omicron variant on molecular diagnostic tests.
|
|
|
|
